Filippa Stenberg

Filippa Stenberg has a diverse work experience. Filippa started their career as a Trainee at Swedbank LC&I in 2010 and later worked there as an Analyst ECM. In 2012, they joined Investor AB as an Analyst and subsequently held roles as an Associate, Senior Associate, and Investment Manager before becoming the Managing Director in December 2022. Additionally, they served as a Board Member at Sobi - Swedish Orphan Biovitrum AB (publ) from May 2021 onwards. Currently, they are the Head of Group Strategy (1-year secondment) at Atlas Antibodies, starting from April 2022.

Filippa Stenberg attended the Stockholm School of Economics from 2006 to 2011, where they pursued a Master's degree in Accounting and Financial Management.